Abstract
Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis.
Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches.
Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.
Keywords: Cancer metabolism, glycolysis, lipogenesis, prostate cancer, renal cell carcinoma, warburg effect.
Current Drug Metabolism
Title:Metabolic Alterations in Renal and Prostate Cancer
Volume: 17 Issue: 2
Author(s): Chiara Ciccarese, Matteo Santoni, Francesco Massari, Alessandra Modena, Francesco Piva, Alessandro Conti, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giampaolo Tortora and Rodolfo Montironi
Affiliation:
Keywords: Cancer metabolism, glycolysis, lipogenesis, prostate cancer, renal cell carcinoma, warburg effect.
Abstract: Background: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis.
Objective: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches.
Method: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. Results and Conclusion: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.
Export Options
About this article
Cite this article as:
Ciccarese Chiara, Santoni Matteo, Massari Francesco, Modena Alessandra, Piva Francesco, Conti Alessandro, Mazzucchelli Roberta, Cheng Liang, Lopez-Beltran Antonio, Scarpelli Marina, Tortora Giampaolo and Montironi Rodolfo, Metabolic Alterations in Renal and Prostate Cancer, Current Drug Metabolism 2016; 17 (2) . https://dx.doi.org/10.2174/1389200216666151015112356
DOI https://dx.doi.org/10.2174/1389200216666151015112356 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aptamers in Targeted Nanotherapy
Current Topics in Medicinal Chemistry Editorial from Guest Editor (DNA Methylation: A Target for Current and Future Therapies?)
Epigenetic Diagnosis & Therapy (Discontinued) Application of Functional Genomics to Bronchial Asthma
Current Pharmacogenomics Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets
Current Signal Transduction Therapy Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis
Anti-Cancer Agents in Medicinal Chemistry ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions
Current Drug Targets The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology mTOR Inhibition and the Tumor Vasculature
Current Angiogenesis (Discontinued) Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Current Radiopharmaceuticals Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry Polyglandular Autoimmune Syndromes
Current Immunology Reviews (Discontinued) A Review on Exploring Better Safety Prospects in Managing Cancer using Liposomal Combinations of Food Bioactive Compounds and Anticancer Drugs: Combisomes
Current Drug Delivery Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Cell Cycle and Energy Metabolism in Tumor Cells: Strategies for Drug Therapy
Recent Patents on Anti-Cancer Drug Discovery Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors in Cancer
Current Drug Targets microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design